1) Hepatitis B Virus preS1-antigen
HBV前S1抗原
1.
Hepatitis B Virus preS1-antigen HBV-DNA,and HBV Markers in Patients with Hepatitis B:Correlation Studies
目的比较乙型肝炎患者HBV前S1抗原(preS1-Ag)与HBV血清标志物、HBV-DNA之间的关系,探讨preS1-Ag检测的临床应用价值。
2) Pre-S1 antigen
前S1抗原
1.
The content and significance of HBVM and vary HBV-DNA of pre-S1 antigen detected by FQ-PCR;
FQ-PCR检测乙型肝炎HBVM和前S1抗原不同模式的HBV-DNA含量及意义
2.
The clinical value of hepatitis B Virus Pre-S1 antigen;
乙型肝炎病毒前S1抗原的临床诊断价值
3.
Correlation between the e-antigen, Pre-S1 antigen, Pre-S2 antigen and DNA of hepatitis B virus;
乙型肝炎e抗原、前S1抗原、前S2抗原与乙型肝炎病毒DNA关系探讨
3) PreS1
前S1抗原
1.
Study relation between the level of serum HBV-DNA and PreS1 and HBeAg;
乙型肝炎患者血清HBV-DNA载量与前S1抗原和e抗原关系探讨
2.
Objective:To study the relationship among HBV-DNA、PreS1 and HbeAg in Patients with Hepatitis,and evaluate the clinical significance of PreS1.
目的:分析乙型肝炎患者血清病毒DNA(HBV-DNA)与前S1抗原(PreS1)及e抗原(HBeAg)的关系,评价PreS1的临床检测意义。
4) Pre S1 antigen
前S1抗原
1.
Methods Pre S1 antigen and HBV serum marker in 269 patients with positive HbsAg were detected by using ELISA method and compared.
目的了解前S1抗原和乙型肝炎病毒(HBV)血清标志物常见模式之间的关系,探讨前S1抗原检测的临床意义。
2.
Objective:To investigate the relativity between Pre S1 antigen and hepatitis B virus serum markers(HBV M).
目的 :探讨乙型肝炎病毒前S1抗原与HBV血清标志物 (即“乙肝五项”)之间的相关性。
5) preS1 antigen
前S1抗原
1.
The clinical significance of the PreS1 antigen in the HBV infected patients of different serologic models;
不同血清学模式乙肝患者前S1抗原的临床意义
2.
Clinical Significance of Detecting the Serum PreS1 Antigen in 267 Patients with Heptatitis B Virus;
267例乙型肝炎病毒前S1抗原检测的临床意义
3.
Clinical significance of combined detection of PreS1 antigen and hepatitis B virus serum markers in parturient women;
临产妇前S1抗原与乙型肝炎“两对半”联合检测的意义
6) Pre-S1
前S1抗原
1.
The value of Pre-S1 in the therapy of type B hepatitis with interferon;
前S1抗原在干扰素治疗乙型肝炎时的应用价值
2.
The detection of serum HBVDNA and Pre-S1 in patients with HBV precore mutant;
HBV-Pre-C区段变异患者血清HBVDNA和前S1抗原的检测
3.
The HBV Pre-S1 Detection Results of Out-patients and Hospital Patients at Certain Hospital in 2004;
2004年某医院门诊和住院病人HBV前S1抗原检测结果
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条